Strides Pharma’s Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) for the quarter increased by 14.7% from the year-ago quarter to ₹217.9 crore, while margins expanded by 150 basis points to 19.5% from 18% last year.
Strides Pharma’s Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) for the quarter increased by 14.7% from the year-ago quarter to ₹217.9 crore, while margins expanded by 150 basis points to 19.5% from 18% last year.